Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

AMGEN ($AMGN) Releases Q4 2025 Earnings

None

AMGEN ($AMGN) posted quarterly earnings results for Q4 2025 on Tuesday, February 3rd. The company reported earnings of $5.29 per share, beating estimates of $4.83 by $0.46. The company also reported revenue of $9,866,000,000, beating estimates of $9,661,541,071 by $204,458,929.

You can see Quiver Quantitative's $AMGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

AMGEN Insider Trading Activity

AMGN Insider Trades

AMGEN insiders have traded $AMGN stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $AMGN stock by insiders over the last 6 months:

  • MURDO GORDON (EVP, Global Commercial Ops) sold 6,879 shares for an estimated $2,317,071
  • NANCY A. GRYGIEL (SVP & CCO) has made 0 purchases and 3 sales selling 4,406 shares for an estimated $1,434,946.
  • RACHNA KHOSLA (SVP, Business Development) sold 890 shares for an estimated $299,255

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AMGEN Hedge Fund Activity

We have seen 1,301 institutional investors add shares of AMGEN stock to their portfolio, and 1,306 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AMGEN Congressional Stock Trading

Members of Congress have traded $AMGN stock 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $AMGN stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AMGEN Analyst Ratings

Wall Street analysts have issued reports on $AMGN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • BMO Capital issued a "Outperform" rating on 12/03/2025
  • Piper Sandler issued a "Overweight" rating on 11/14/2025
  • B of A Securities issued a "Underperform" rating on 09/26/2025

To track analyst ratings and price targets for AMGEN, check out Quiver Quantitative's $AMGN forecast page.

AMGEN Price Targets

Multiple analysts have issued price targets for $AMGN recently. We have seen 9 analysts offer price targets for $AMGN in the last 6 months, with a median target of $325.0.

Here are some recent targets:

  • Michael Yee from UBS set a target price of $390.0 on 01/26/2026
  • Courtney Breen from Bernstein set a target price of $335.0 on 01/20/2026
  • Gregory Renza from Truist Securities set a target price of $319.0 on 01/08/2026
  • Terence Flynn from Morgan Stanley set a target price of $304.0 on 12/12/2025
  • Mohit Bansal from Wells Fargo set a target price of $325.0 on 12/10/2025
  • Evan David Seigerman from BMO Capital set a target price of $372.0 on 12/03/2025
  • David Amsellem from Piper Sandler set a target price of $381.0 on 11/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles